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Abstract
The emergence of engineered nanoscale materials has provided significant advancements in 
electronic, biomedical, and material science applications. Both engineered nanoparticles and 
nanoparticles derived from combustion or incidental processes exhibit a range of physical and 
chemical properties, which have been shown to induce inflammation and oxidative stress in 
biologic systems. Oxidative stress reflects the imbalance between the generation of reaction 
oxygen species (ROS) and the biochemical mechanisms to detoxify and repair resulting damage of 
reactive intermediates. This review examines current research incidental and engineered 
nanoparticles in terms of their health effects on the lungs and mechanisms by which oxidative 
stress via physicochemical characteristics influence toxicity or biocompatibility. Although 
oxidative stress has generally been thought of as an adverse biological outcome, this review will 
also briefly discuss some of the potential emerging technologies to use nanoparticle-induced 
oxidative stress to treat disease in a site specific fashion.
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INTRODUCTION
The emergence of engineered nanoscale materials has shown promise for significant 
advancements in the fields of imaging, electronics, and therapeutics (1–7). Although 
nanotechnology may be an emerging field, the study of particles less than 100 nm in 
diameter (also known as ultrafine particles), has been ongoing for decades. Nanoparticles 
come from many different sources; they exist naturally in the environment (forest fires, 
viruses, volcanoes), are produced as byproducts of industrial or combustion processes 
(engines, power plants, incinerators), and are intentionally made for various industrial or 
consumer product applications (pigments, chemical catalysts). The emergence of 
nanotechnology has added a new type nanoparticle to this list, specifically engineered 
nanoparticles. Nanotechnology has been defined as a field that “involves a wide range of 
technologies that measure, manipulate, or incorporate materials and/or features with at least 
one dimension between approximately 1 and 100 nanometers (nm). Such applications 
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exploit the properties, distinct from bulk/macroscopic systems, of nanoscale components” 
(8).
Engineered nanomaterials being developed today are produced in a variety of compositions 
(metal, elemental semiconductor, compound semiconductor, metal oxide), shapes (spiral, 
wire, belt, spring, pillar, helix, etc.), and structures (core/shell, single composition). 
Similarly, nanoparticles derived from combustion or incidental processes exhibit a range of 
physical and chemical properties. Incidental nanoparticles generated from combustion 
processes have the potential for aggregation forming accumulation mode particles with very 
unique physical and chemical characteristics (9–11). While transition metals and polycyclic 
aromatic hydrocarbons (PAHs) are primary components of these ambient particles, both 
engineered and incidental nanoparticles can be high in carbon and metal content. Research 
has shown relationships between these different physicochemical characteristics of 
nanoparticles and the induction of inflammation and oxidative stress in biologic systems.
Oxidative stress reflects the imbalance between the generation of reaction oxygen species 
(ROS) and the biochemical mechanisms to detoxify and repair resulting damage of reactive 
intermediates. The imbalances in the cellular oxidative state can lead to generation of 
peroxides and free radicals, which in turn can damage proteins, lipids and DNA. Because 
ROS act as cellular messengers in redox signaling, oxidative stress can lead to interferences 
in normal cell signaling. Due to the belief that oxidative stress plays an important role in 
several neurodegenerative and cardiovascular diseases and is likely involved with the 
development of age-related cancer, a significant amount of research has been invested over 
the last several decades to better understand the pathophysiological effects of oxidative 
stress and the implications for the natural history of disease processes.
The purpose of this review is to examine the role of oxidative stress on the health effects of 
nanoparticles on the lung. Current research of well-studied nanoparticles, such as ambient 
ultrafine particles, as well as emerging engineered nanomaterials, such as carbon nanotubes, 
will be evaluated in terms of their health effects on the lungs and mechanisms by which 
oxidative stress via physicochemical characteristics influence toxicity or biocompatibility of 
nanoparticles. Readers are directed to recent reviews on studies and methods to measure 
oxidative stress from exposure to nanoparticles and proposed screening approaches to 
predict nanoparticle toxicity or biocompatibility (12, 13). Although oxidative stress has 
generally been thought of as an adverse biological outcome, this review will also briefly 
touch on some of the potential emerging technologies to use nanoparticle-induced oxidative 
stress to treat disease in a site specific fashion (e.g., Alzheimer’s disease).
MECHANISMS OF OXIDATIVE STRESS
Nanoparticle-induced oxidative stress is thought to occur through a number of different 
mechanisms as a result of intrinsic properties of nanoparticles, as well as through extrinsic 
nanoparticle-cellular interactions (Figure 1). Nanoparticles themselves can have oxidant-
generating properties. Transition metals, which can be major or trace contaminants of 
incidental or engineered nanoparticles, can catalyze the production of hydroxyl radical from 
hydrogen peroxide via Fenton-like reactions, which in turn can initiate lipid peroxidation. 
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Stable free radical intermediates present on reactive particle surfaces (such as that seen with 
quartz) and redox active groups (e.g., quinones) on functionalized nanoparticles can be a 
source of intrinsic particle oxidant sources (14–18). Cells, such as macrophages and 
neutrophils, can act as potent generators of ROS in response to their interactions with 
nanoparticles. Mitochondria are the major source of ROS through normal mechanisms of 
cellular respiration; however, if imbalances occur between oxidant generation and 
expression of antioxidant enzymes and proteins, oxidant stress can ensue. Recent studies 
have also suggested that ROS-producing mitochondria can prompt inflammasome activation 
of phagocytic cells, thus providing the cell signaling link between mitochondria and 
inflammation (16, 19). Ultimately, whether ROS originate from the particles themselves 
and/or through the cellular response to nanoparticles, oxidative stress and accumulation of 
oxidative products can lead cell damage and death when the equilibrium between pro- and 
antioxidants is disrupted.
Endogenous sources of ROS are generated by many cellular and enzymatic players. A 
primary source of ROS is the generation of a wide variety of oxidants through phagocytic 
respiratory bursts of macrophages and neutrophils. Much of the understanding of cellular 
based synthesis of ROS was developed through investigation of antimicrobial systems used 
by leukocytes in which bacterial killing is facilitated by the generation of a variety of highly 
effective bactericidal agents, including superoxide anion, hydrogen peroxide, and halo-
oxygen species such as HOCl. The respiratory burst is a metabolic event in which cells 
manufacture large quantities of highly reactive oxidants in response to a stimulus and is a 
cyanide insensitive rapid utilization of oxygen and glucose. Leukocytes, such as neutrophils 
and macrophages, produce ROS during phagocytosis or stimulation with a wide variety of 
agents through activation of nicotinamide adenine dinucleotide phosphate reduced 
(NADPH) oxidase (20). The capacity for this rapid response is regulated by protein 
phosphorylation of key subunit, p47phox, a 45 kDa oxidase component that is extensively 
phosphorylated when the oxidase is activated. This subunit moves to the phagosomal 
membrane where, as it organizes with the remaining components of the active enzyme, it 
generates electrons to reduce molecular oxygen (21). The organized oxidase complex acts 
through a catalytic subunit (gp91phox, also known as NOX2) to bind NADPH, extract 
electrons, and transport them across the phagosomal membrane to react with oxygen through 
an iron-heme complex, thus secreting superoxide into the lumen (22). Differentiated 
macrophages (such as alveolar macrophages: AM) also generate ROS using NOX2 based 
metabolism but lack the myeloperoxidase (MPO) present in neutrophils that is necessary for 
HOCl generation. Macrophages also generate nitrogen-based radicals through NO synthase 
and its interaction with active oxygen species. It is now becoming clear that non-phagocytic 
cells use similar reactive oxygen generating enzyme complexes for both innate defense and 
intracellular signaling (23).
The balance between the pathological or protective mechanisms of ROS is most apparent in 
the normal biochemical machinery of the mitochondria. Mitochondria are major producers 
of ROS and also may be major targets for oxidative damage. This delicate balance between 
ROS generation in meeting cellular energy demands versus perturbations that lead to 
dysfunction, cell death, and disease has been a major area of research to better understand 
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the fundamental attributes of mitochondria and the role of mitochondrial dysfunction in 
generating disease (24, 25).
Cellular pathogenesis can be initiated and enhanced by mitochondrial oxidative stress. 
Mitochondrial ROS is generated in the respiratory chain during ATP synthesis due to 
leakage of electrons from mitochondrial complexes I, II, and III (26). While basal levels of 
ROS are maintained by cellular and mitochondrial antioxidants, perturbations can lead to 
mitochondrial oxidative stress, which in turn can result in interruption of the energy supply, 
calcium imbalances, release of lethal proteins, and a culmination of changes that lead to 
apoptosis or necrosis. While severe mitochondrial oxidative stress can produce pathological 
dysfunction that leads to apoptosis or necrosis, minor ROS generation is thought to create a 
protective “preconditioning” against a subsequent “severe” oxidative stress attack (26).
A hierarchical oxidative stress model has been proposed as a possible explanation of the 
differential effects of “minor” versus “severe” oxidative stress. In this hierarchical oxidative 
stress model, “minor” oxidative stress triggers antioxidant protection, whereas “higher” 
oxidant stress initiates specific signaling and gene expression pathways that can cause 
cellular and organelle injury and cell death (27–29). Oxidative stress is an imbalance or 
disequilibrium of the redox state of a cell with cellular glutathione (GSH) and glutathione 
disulfide (GSSG) being primary regulators of the redox balance. The extent and rate by 
which GSH/GSSG levels are changed can determine whether stress responses are protective 
or injurious in nature (30–32). Figure 2 illustrates the careful balance between antioxidant 
and prooxidant mechanisms and the implications for maintaining biochemical homeostasis 
or leading to oxidant disruption that translates into cellular toxicity. In the hierarchical 
oxidative stress model, antioxidant defense, inflammation, and toxicity are defined as the 
three tiers along the continuum of adaption and compensation of oxidant stresses to an 
imbalance whereby the protective antioxidant mechanisms breakdown or are overwhelmed. 
In the first tier, protective antioxidant and detoxifying enzymes are induced. Heme 
oxygenase (HO-1), glutathione-S-transferase (GST), NADPH quinine oxidoreductase, 
catalase, superoxide dismutase (SOD), and glutathione peroxidase are examples of enzymes 
that influence and regulate cellular oxidant capacity (31, 33–36). In the second tier of the 
oxidant stress paradigm, proinflammatory processes are initiated when ROS production 
surpasses the antioxidant protective mechanisms. These proinflammatory effects are 
mediated by redox-sensitive MAP kinase and NF-κB cascades, which initiate the expression 
of cytokines, chemokines and adhesion molecules involved with the inflammatory process 
in the lungs (28, 30–33). In the third tier of the oxidant stress model, cytotoxicity involving 
perturbation of mitochondrial permeability and electron transfer in organelle respiration 
results in cellular apoptosis or necrosis (31, 32, 37).
While it has been well understood that the generation of ROS plays an important role in the 
pathogenesis of highly surface reactive particles like quartz and asbestos (38–41), it was not 
until research on nanosized and fine sized low-toxicity, low-solubility particles (i.e., 
titanium dioxide, carbon black and polystyrene beads) that particle size was also appreciated 
as an important factor in the role of ROS-mediated cytotoxicity (42–48). For example, 
exposure to polystyrene nanoparticles, which are thought to be relatively inert because they 
do not spontaneously produce ROS, resulted in lysosomal leakage, ROS production and 
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mitochondrial damage that led to apoptosis in murine macrophages (29, 31). This work 
clearly showed that nanoparticles lacking surface chemical reactivity are still capable of 
inducing ROS through biological interactions that directly or indirectly target the 
mitochondria. Since the early studies of low-toxicity, low-solubility particles, researchers 
have sought to better understand the role and mechanisms by which oxidative stress is 
generated, biochemical processes are disrupted, and cellular damage is induced from 
incidental and engineered nanosized particles. The subsequent sections of this chapter 
address pulmonary health effects resulting from exposure to incidental ambient 
nanoparticles and engineered carbon nanotubes and what is currently understood in regards 
to the involvement of oxidative stress in the pathology associated with these two types of 
nanoparticles.
INCIDENTAL NANOPARTICLES
Health Effects and Lung Injury
Particulate air pollutants are complex mixtures derived from a variety of anthropogenic and 
natural sources. Ambient particulate matter (PM) can cause effects on the respiratory system 
that are similar to particulates found in occupational settings; however, extrapulmonary 
changes (e.g., cardiovascular effects) have also been documented from peak exposures to 
ambient PM. While research of the effects of ambient PM over the last few decades have 
focused on the PM in the coarse- and fine-sized fractions, considerable efforts have recently 
been spent understanding the role that ultrafine particles may play in either contributing or 
exacerbating cardiopulmonary disease in normal and susceptible populations. It should be 
noted, however, particularly in the era of nanotechnology, that researchers are now referring 
to ambient ultrafine particles as “nanosized particles produced by incidental means” to make 
the distinction from engineered nanoparticles.
Dissimilar size fractions of ambient PM have very different physicochemical characteristics, 
partly because of their emission sources. Coarse particles are generally comprised of natural 
materials (i.e., minerals, silicates, pollen) derived from weathering and disturbance of earth 
soils, whereas fine particles usually originate from anthropogenic sources (i.e., combustion 
processes, industrial emissions) and are comprised of a mixture of elemental and organic 
carbon, sulfate, nitrate, minerals, and metals. Ultrafine PM is also generated through 
combustion processes, but can quickly aggregate to form larger sized particles (9–11).
Episodes of intense particulate air pollution have been known to cause increased morbidity 
and mortality for at least a half-century. The Donora death fog in 1948 and the London fog 
in 1952 were notable air pollution events that led to upwards of a few thousand excess 
deaths and, more recently, the work from the Harvard six cities studies in 1993 showed that 
peak particulate air pollution events led to increased deaths from lung cancer and 
cardiopulmonary disease (49). Over the last decade, over 100 studies of more than 35 
different cities have investigated the acute effects of ambient PM showing increased hospital 
admissions and deaths from cardiopulmonary disease (e.g., asthma, chronic obstructive 
pulmonary disease, arrhythmia, heart attack) (50–52). The effects appear to best correlate 
with PM2.5 with an increased mortality of 0.5 to 1.5% for every incremental concentration 
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increase of 5 µg/m3 (51). These studies have served as a basis for the National Ambient Air 
Quality Standard for PM (10).
There is considerably less information about the chronic effects of ambient particulate 
pollution. Although lung tissue remodeling is known to occur from exposure to ambient PM, 
these changes tend to be less prevalent and severe compared to that observed in occupational 
settings. Autopsy studies have provided some means for assessing the potential long-term 
effects of exposure to ambient PM. Findings from these studies have suggested that long-
term exposures to ambient PM can lead to remodeling of the lungs with the most significant 
changes occurring in the respiratory bronchioles and bronchoalveolar duct junctions or 
centriacinar regions of the lungs. Pinkerton et al. (2000), for example, evaluated lungs of 
deceased young males in California’s Central Valley who died of non-respiratory causes. 
The individuals had been exposed to ambient conditions consisting primarily of mineral and 
carbonaceous dusts. Dust deposition was principally observed in tissue sections at the 
terminal bronchioles and first-generation respiratory bronchioles, with less deposition 
observed in the upper airways (Figure 3). There was significant wall thickening via 
inflammatory cell accumulation (dust laden macrophages), increased collagen deposition, 
and smooth muscle cell hypertrophy, resulting in terminal and first-generation respiratory 
bronchiole structural remodeling. Changes in lung structure and retention of particles 
appeared to be inversely proportional to the distance from the center of the lung acinus; 
particle retention decreased from the first-generation, to second-generation, to third-
generation of respiratory bronchioles (Figure 4). The effects seen in the respiratory 
bronchioles were also observed in the lungs of both smokers and non-smokers, with more 
severe changes occurring in smokers. It was suggested that there might be synergistic effects 
between ambient PM and cigarette smoke, but despite any interactions, respiratory 
bronchiole remodeling as a result of exposure to ambient PM could be detected irrespective 
of the smoking status (53).
The findings from Pinkerton and colleagues have also been observed in other PM exposed 
populations. Subjects living in high-PM areas in Canada showed increased particle 
deposition in the respiratory bronchioles and at airway bifurcations that correlated with 
airway remodeling (54, 55). These studies have shown correlations of high ambient PM 
exposure to particle deposition and airway remodeling in the lungs with indications that fine 
(≤PM2.5) and aggregations of ultrafine particles (≤PM0.1) are likely the particle size fraction 
contributing to these effects because of their prevalence in lung tissue digests (53, 56). 
Further studies comparing individuals exposed to non-occupational, high ambient PM have 
indicated that ultrafine particles retained in the bronchiole airway walls are associated with 
fibrogenic small airway remodeling and may produce a chronic airflow obstruction (57). 
Although these results may suggest possible effects from long-term exposures to ambient 
particulate air pollution, it is important to keep in mind that other confounders (e.g., genetic, 
lifestyle, smoking, occupational exposures, other ambient pollutants) may have some 
contribution to these effects and may not be fully accounted for in the individual case history 
(53, 55–59).
As a means to understand the potential chronic effects of ambient PM, researchers have 
utilized tracheal explants as a model system for controlling the administered PM dose to a 
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particular region of the lungs. More specifically, it has been shown that particles (collected 
ambient PM, mineral dusts, and diesel exhaust PM) administered into the airway leads to 
expression of mediators promoting fibrosis and smooth muscle hyperplasia. The expression 
occurs without exogenous inflammatory cells, and suggests PM may directly cause 
epithelial cell injury, airway remodeling, and possible obstruction even in the absence of 
inflammation (60, 61). Further, studies of concentrated ambient particles (CAPs) have 
shown both pulmonary and extrapulmonary effects, including up-regulation of pro-
inflammatory genes and markers of oxidative stress in the lungs, as well as systemic effects 
suggesting an increased risk of arthrosclerosis (59, 62, 63).
Role of Oxidative Stress
Oxidative stress has been identified as one of the primary mechanisms by which ambient 
particulate air pollution exerts adverse health effects. Of the varying sizes of ambient PM, 
nanosized particles are thought to be potentially the most hazardous due to the their small 
size, large surface area, and high relative content of redox-cycling organic chemicals with 
the ability to penetrate, deposit, and be retained in the deep lung (28, 31). Many of the 
components of nanosized ambient PM, such as metals and organic carbon compounds, are 
capable of ROS generation through Fenton and Haber Weiss chemistry, as well as redox 
cycling of organic chemicals (i.e., quinones), which form superoxide radicals (30, 31). The 
ability of ultrafine particles (PM0.1) to generate more free radicals than coarse (PM10) and 
fine particles (PM2.5), as measured by induction of heme oxygenase and depletion of 
intracellular glutathione, may be due to ultrafine particles having a large surface area for 
adsorption of ROS-generating components (64). Inherent ROS generation is commonly 
associated with transition metals, such as iron (Fe), copper (Cu), nickel (Ni), cobalt (Co), 
and vanadium (V). These metals are associated with anthropomorphic sources, with Fe 
having an order of magnitude greater concentration in most samples from polluted regions 
(65). Transition metals such as Fe catalyze the production of hydroxyl radical from 
hydrogen peroxide via Fenton-like reactions that are enhanced in the presence of 
physiological concentrations of ascorbate (Figure 1) (66). Using metal chelators or 
antioxidants to ameliorate the oxidative stress induced by PM have shown that metals play 
an important role in the pro-oxidant and proinflammatory effects of ambient PM (31, 67).
In addition to transition metals, environmental PM contains PAHs and quinones and that 
undergo redox cycling to generate ROS. In the burning of hydrocarbons, radicals formed 
early in combustion interact, forming PAHs, including carcinogens, from less complex 
structures. PAHs will aggregate into nanoparticles, which can extend into branched-chain 
structures observed as black smoke or soot (68). Quinones are derived from PAH 
components and likely include such compounds as 1,4-naphthoquinone; 5,12-
naphthacenequinone; bez[a]anthracene-7,12-dione; and anthracene-9,10-dione. These 
quinones undergo cyclic reduction reactions with oxygen followed by oxidative coupling 
with either NADPH or iron to form semiquinones leading to the formation of superoxide 
radicals (69). Quinones are not only by-products of fuel combustion, but also are generated 
by the enzymatic conversion of PAH in the lungs (31, 70, 71).
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The toxic potential of PM in ambient air or from combustion processes has been shown to 
correlate with the chemical composition and the capacity to induce oxidative stress (31, 72, 
73). Studies of concentrated ambient particles (CAPs) show that nanosized particles, which 
contain a significant amount of PAHs and quinones, have a greater potency to induce 
oxidative stress in macrophages and epithelial cells than coarse PM, which is mostly 
comprised of crustal elements (31, 72). Similarly, quinones and PAHs in diesel exhaust 
particles have been shown to contribute to oxidant injury of the lung (31, 74–76). It has also 
been suggested that oxidative stress generated from organic chemicals on the surface of 
combustion particles are responsible for not only proinflammatory effects, but also adjuvant 
effects in the respiratory tract, which can lead to nonspecific and allergic inflammatory 
processes (31, 73). Interestingly, pretreatment of SOD or nitric oxide synthase inhibitors 
significantly diminished inflammatory cell infiltration, mucus and nitric oxide production, 
and increased airway hyperreactivity (effects involved in the pathogenesis of asthma), 
emphasizing the role of oxidant stress on inflammatory processes and pathological outcomes 
(31, 77–79). Similarly, thiol-antioxidants (i.e., N-acetyl-cysteine) suppressed adjuvant 
effects of diesel exhaust particles on ovalbumin induced allergic responses (31, 80). The 
importance of the role of antioxidant and enzyme detoxification pathways has been further 
emphasized by the observation of increased nasal allergic and allergen-specific IgE 
responses in individuals who exhibit GST M1-null genotype following exposure to diesel 
exhaust particle (31, 81). In conclusion, while recent research has provided a better 
understanding of the potential drivers of oxidative stress from ambient PM, the complexity 
of particle-cellular interactions and the associated intrinsic and extrinsic sources of ROS still 
leaves much to be evaluated in terms of defining the role and molecular pathways by which 
oxidative stress leads to PM induced disease processes.
ENGINEERED NANOMATERIALS
Health Effects and Lung Injury
Although nanoscale particles (<100 nm diameter) resulting from manufacturing (i.e., 
ultrafine titanium dioxide [TiO2] or carbon black) or combustion processes (i.e., vehicle 
exhaust, air pollution) have been studied extensively for decades, the potential 
biocompatibility and toxicity of engineered nanomaterials have only recently received 
attention from the scientific community. Carbon-based engineered nanoparticles, such as 
single-walled carbon nanotubes (SWCNTs), multi-walled carbon nanotubes (MWCNTs), 
and fullerenes, have received notable attention due to their superior electronic, optical, 
mechanical, chemical, and even biological properties. Questions have been raised as to 
whether the unique properties of these materials may exert biological effects distinct from 
their parent material (82, 83). Carbon nanotubes are hollow graphite tubes that can be 
visualized as a single sheet of graphite rolled to form a cylinder. Carbon nanotubes are 
comprised of either a single layer (e.g., SWCNT) or multiple layers of individual SWCNTs 
stacked within one another (e.g., MWCNT), and are manufactured either by electrical arc 
discharge, laser ablation, or chemical vapor deposition processes (84, 85).
The type of carbon nanoparticle (i.e., SWCNT, MWCNT, fullerene), method of processing 
(i.e., refined or unrefined), presence of residual transition metal catalysts, and functionality 
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of different reactive groups are a few of the parameters researchers have tested in cultured 
cells to better understand which physicochemical characteristics influence toxicity (86–89). 
SWCNTs, for example, appear to have greater toxic effects on cultured human fibroblasts 
than MWCNT, active carbon, carbon black, and graphite carbon. In addition, acid treatment 
(a method of carbon nanotube refinement and removal of residual metal catalysts) of 
SWCNT produced more toxicity than its unrefined counterpart (89). These findings are 
supported by other studies that show that acid treatment and subsequent functionalization of 
SWCNT or fullerenes influence the extent of toxicity on human lung-tumor cell lines and 
primary immune cells (86–88). The addition of carbonyl-, carboxyl, or hydroxyl groups on 
the surface of carbon nanotubes induces cell death in lung tumor cells (87). 
Functionalization of SWCNTs with water-soluble functional groups appears to influence 
cellular specific uptake and tolerance by primary immune cells, whereas nonfunctionalized 
carbon nanotubes induce oxidative stress and apoptosis in a variety of cell systems (90–95).
While clear toxicological differences between carbon nanoparticles functionalized with 
different chemical moieties have been observed with in vitro cell systems, these same 
responses are not always seen when administering the same material in vivo. The different 
toxicity responses of in vitro versus in vivo studies has been specifically observed with 
functionalized fullerenes administered to different human cell lines (dermal fibroblasts, lung 
epithelial cells, astrocytes) compared to pulmonary responses of rats administered the same 
material by intratracheal instillation (88, 96). As for in vivo studies conducted on carbon 
nanotubes, most investigators report inflammation, progressive fibrosis, and granulomas in 
rodents exposed to carbon nanotubes via intratracheal installation or pharyngeal aspiration. 
More specifically, as a result of these exposures, acute dose-dependent changes in alveolar 
wall thickness, immune cell recruitment, and indicators of cellular damage and oxidative 
stress (measured by levels of inflammatory cells, cytokines, and protein in bronchoalveolar 
lavage) were observed (97–101). Carbon nanotubes also produce pulmonary function 
deficits, impairment of bacterial clearance, aortic plaques, and atherosclerotic lesions (99, 
102–104).
In an attempt to understand how different physical and chemical parameters contribute to 
toxicological effects, researchers have evaluated the impact of the method of carbon 
nanotube production, as well as the influence of milling carbon nanotubes or altering the 
content and type of metal catalyst on the toxicity in animals (98, 105, 106). Results suggest 
that all of the various formulations of carbon nanotubes produce pulmonary lesions (97). A 
relatively recent published study shows that these effects can be exacerbated by feeding 
animals a vitamin E-deficient diet, and thereby reducing the antioxidant capacity 
(glutathione, ascorbate, α-tocopheral) of the lungs while enhancing acute inflammation and 
fibrotic responses (101).
A few inhalation studies of SWCNTs and MWCNTs using a variety of aerosol delivery 
systems have recently been published in an attempt to address whether the pulmonary 
effects of CNTs can be attributed to the method of administration (e.g., pharyngeal 
aspiration or intratracheal instillation) or the toxicity of the particle itself (107–115). Based 
on these recent studies, there appears to be a difference in the pattern and extent of 
pathology across the different types of nanomaterials (SWCNT versus MWCNT), as well as 
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approaches for delivery to the respiratory tract (aspiration versus inhalation). MWCNTs 
delivered by intratracheal instillation or pharyngeal aspiration produces inflammation and 
fibrosis biochemically and histologically at delivered doses up to 5 mg per rat (98, 116), 
whereas inhalation of aerosolized MWCNTs produces mixed results. For example, no 
pulmonary lesions were observed following exposure to 100 mg/m3 MWCNTs for 6 hr 
(109) or 5 mg/m3 MWCNTs for 14 days (108). In fact, in one study, inflammatory responses 
in the spleen were more sensitive to MWCNT exposures than that observed in the lungs 
(108). In mice exposed by inhalation to 0.3, 1 or 5 mg/m3 MWCNTs for 7 or 14 days 
(followed for 7 and 14 days post-exposure), alveolar macrophages in bronchoalveolar lavage 
and in lung tissue sections contained black particles, but without elevations of white blood 
cell counts in bronchoalveolar lavage or oxidant stress markers or pathology in the lungs. 
Changes in immunosuppression markers (e.g., T-cell antibody and proliferative response) 
and cytokine gene expression of IL-10 and NAD(P)H oxidoreductase, however, were 
observed in the spleen (108).
In contrast to the negative pathological changes in the above noted studies, other researchers 
have reported thickening of alveolar walls following exposure to 32 mg/m3 MWCNTs for 
15 days (107), lung injury and fibrosis under conditions of pre-existing allergic 
inflammation following exposure to 100 mg/m3 MWCNTs for 6 hr (109), inflammation and 
granuloma formation following exposure to 0.5 or 2.5 mg/m3 MWCNTs for 90 days or 0.4 
mg/m3 MWCNTs for 13 weeks (113, 114), and subpleural fibrosis and mononuclear cell 
aggregates following a single 6 hr exposure to 30 mg/m3 MWCNTs (115). To evaluate the 
effects of inhaled carbon nanotubes, researchers have used a variety of systems, such as a 
nebulizer, jet mill and powder generator, to aerosolize these carbon-based nanomaterials 
with median mass aerodynamic diameters (less than 2 µm) within the respirable size range.
In comparison, studies of SWCNTs have reported pulmonary inflammation, interstitial 
fibrosis, and granulomas following exposure by instillation, pharyngeal aspiration, and 
inhalation (97–101, 110, 117). In two studies published by researchers at NIOSH, it has 
been suggested that administration of dispersed SWCNTs, either by aspiration or inhalation, 
increase collagen and alveolar wall thickness compared to less dispersed forms of SWCNTs 
delivered by aspiration (110, 117). It has been proposed that SWCNTs elicit these responses 
by generation of ROS mediated through the presence of residual iron catalysts decorated on 
the surface of the SWCNTs as well as through release of inflammatory mediators. Although 
it has been shown that MWCNTs are clearly recognized by alveolar macrophages (108, 
109), it has been suggested that evasion of SWCNTs from macrophage phagocytosis might 
contribute to their facilitated translocation to the interstitium, where the production of 
collagen is stimulated. Whether macrophage clearance and transepithelial migration, or 
differences in physicochemistry, can explain the dissimilar pathological patterns in the 
respiratory tract between MWCNTs and SWCNTs will require further investigation.
Because of the elongated and fibrous nature of carbon nanotubes, some researchers have 
suggested analogies between these engineered nanoparticles and asbestos. In fact, two 
studies have compared peritoneal responses of MWCNTs to asbestos following 
intraperitoneal injection. In one study, inflammatory and granuloma responses in the 
peritoneal cavity were assessed following an intraperitoneal injection (50 µg/mouse) of 
Madl et al. Page 10













MWCNTs or amosite asbestos (long fibers of 10–20+ µm length or short fibers of <5 µm 
length) or nanoparticle carbon black (118). It was found that the granulomatous 
inflammation was greatest for long MWCNTs and amosite formulations as compared those 
containing mostly short MWCNTs or amosite fibers. While the response observed with long 
MWCNTs and amosite fibers were similar, the study did not address whether the 
inflammatory or granulomatous changes would go on to develop mesotheliomas (118). 
Although highly criticized for its dosing regimen and animal model selection, Takagi et al. 
(2008) reported mesotheliomas in p53 heterozygous mice following single 3 mg 
intraperitoneal injections of MWCNTs or crocidolite fibers but not in mice injected with 
fullerenes (119). In contrast, a two-year bioassay showed no mesotheliomas as a result of 
single intraperitoneal injections of MWCNTs (with and without structural defects) in mice, 
whereas significant incidence rates of mesothelioma tumors were observed with 
intraperitoneal injections of crocidolite (120). Despite the findings in these three studies, 
further research is clearly needed to evaluate whether any pathological changes in the 
appropriate animal model can lead to tumors following acute exposure to CNTs via relevant 
routes of administration (e.g., inhalation) (118, 121, 122).
Role of Oxidative Stress
Similar to incidental ambient nanoparticles derived from anthropogenic sources, engineered 
nanoparticles can produce ROS and oxidative stress through intrinsic physicochemical 
properties of the nanoparticle, as well as through nanoparticle-cellular interactions with 
immune and epithelial cells in the lungs. There are a number of different proposed 
mechanisms by which engineered nanoparticles produce ROS (28, 31). First, electron-hole 
pairs though UV activation could participate in electron donor or capture interactions that 
generate superoxide or hydroxyl radicals. Second, semiconductor properties could lead to 
electron jumping from the conduction band to oxygen to generate superoxide. Third, 
dissolution of the nanoparticle to release metal ions can catalyze ROS generation and, lastly, 
transition metals on the nanoparticle surface can generate superoxide radicals via Fenton 
chemistry (28, 31). Also, similar to ambient nanosized particles, engineered nanoparticles 
can produce oxidant injury via nanoparticle-cellular interactions and ROS derived from 
inflammatory processes and mitochondrial dysfunction.
Given some of the physicochemical similarities (i.e., presence of transition metals, high 
aspect ratio, potential biopersistence) to other high aspect ratio particles (e.g., asbestos), 
researchers have sought to understand how the role oxidative stress integrates with some of 
the health effects seen in the lung following exposure to CNTs. Studies have generally 
focused on oxidative responses from the presence of residual transition metal catalysts 
associated with the production of SWCNTs and MWCNTs and/or from phagocytic cells as a 
result of phagolysosomal activation. When comparing as-produced SWCNTs (containing 
iron) to purified SWCNTs, where the iron is removed through acid treatment, it has been 
shown that iron-rich SWCNTs are more effective in stimulating hydroxyl radicals in 
zymosan-stimulated RAW 264.7 macrophages and increasing intracellular ROS and 
decreasing mitochondrial membrane potential in rat macrophages and human lung cells than 
purified SWCNTs lacking iron (16, 123, 124). While several studies have shown that the 
presence of transition metals (e.g., iron) is important in determining the redox-dependent 
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responses of macrophages, CNTs have other characteristics that make them unique from 
other toxicants, such as asbestos. Specifically, it has been shown that CNTs may have the 
ability to quench and scavenge free radicals, which has been proposed to be related to the 
presence of structure defects and associated with genotoxic and inflammatory potential (16, 
105, 125).
With the massive oxidizing potential of phagolysosomes, it is likely that oxidative 
modification of phagocytized CNTs may occur. Myeloperoxidase (MPO), a potent oxidant 
enzyme source in neurtrophils, has been shown to biodegrade SWCNTs in an acellular 
system (16, 126). Treatment of biodegradation products of SWCNTs with MPO failed to 
induce pulmonary inflammatory responses in mice after pharyngeal aspiration (16, 126). It 
was also observed that the clearance of SWCNTs from MPO-deficient mice was markedly 
reduced compared to wild-type animals (15, 16). Other carbon-based nanoparticles have 
been shown to undergo similar MPO-catalyzed modifications and degradation (16, 127). It 
has been proposed that hypochlorite and MPO reactive intermediates are possible pathways 
in which the oxidative biodegradation process occurs (15, 16, 127, 128). Certainly the 
biodegradation of SWCNTs has tremendous implications for biopersistence and potential 
long-term health effects from prolonged exposures.
Recent work by Donaldson and colleagues has shown that CNTs are generally durable 
materials but may undergo biological modification (16, 129). Testing the durability of four 
types of CNTs in simulated biological fluid demonstrated that durable CNTs with short or 
tightly bundled aggregates with no long isolated fibers were less inflammogenic than the 
longer CNT counterparts (16, 129). Other studies have shown that biodegradation leads to 
physical and/or chemical modifications. SWCNTs with carboxylated surfaces in artificial 
phagolysosomal fluid can reduce the length of SWCNTs, as well as result in accumulation 
of carbonaceous debris. These biodegradation processes certainly have implications for the 
hazardous potential of these materials.
It has been suggested that CNTs may induce ROS through NADPH oxidase-dependent 
pathways. In NADPH oxidase-deficient mice, SWCNT exposure resulted in an 
accumulation of neutrophils, production of pro-inflammatory cytokines, decreases in anti-
inflammatory and pro-fibrotic cytokines, and less collagen deposition as compared to wild-
type control mice (16, 110). Similarly, deficiency in antioxidant molecules resulted in 
increased sensitivity to the inflammatory effects of SWCNTs. Lower levels of antioxidants 
in vitamin E-deficient mice were associated with greater acute inflammation and enhanced 
pro-fibrotic responses (increase in TGF-β and collagen deposition) following exposure to 
SWCNTs (16, 101). In summary, the research thus far suggests there are multiple factors 
(e.g., CNT chemistry, biodegradation and antioxidant capacity/susceptibility) that can 
influence oxidative stress following exposure to CNTs and further research is needed to 
understand which variables impact or are associated with any progression of pulmonary 
disease.
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NANOTHERAPEUTICS AGAINST OXIDATIVE INJURY
One aspect of toxicity testing of nanoparticles that is worth noting is that cellular toxicity 
may actually be a desired outcome and intended use of the nanoparticle, particularly if the 
target is tumor cells. While research in the area of biocompatible carbon nanotube design is 
still in its infancy, investigators are functionalizing these nanoparticles to have sufficient 
biocompatibility, functionality, distribution, retention, and specificity in hope that these 
nanomaterials can be utilized as carriers of biologic and therapeutic molecules (84, 85). 
Ways in which researchers are manipulating the chemistry of carbon nanotubes for 
pharmaceutical applications include entrapment of active components within the CNT 
matrix or bundle, functional attachment of the compound on the exterior walls of the CNT 
and use of CNT channels as nanocatheters (84, 85). These approaches, as well as the 
dispersive agents used to solubilize the CNTs, can have dramatic effects on the clearance 
and retention of these nanomaterials (130, 131).
Researchers are investigating ways in which nanomaterials can be used to target and 
mitigate or augment endogenous oxidative stress as potential preventative or treatment 
modalities for disease. One example, is the potential use of nanomaterials to transport metal 
chelating agents to pathological sites of significant and abnormal metal accumulation within 
Alzheimer disease patients (132). Transition metal accumulations in Alzheimer disease 
brains are thought to have an important role in local oxidative reactions and pathological 
lesions. Metal-chelating agents with the assistance of nanocarriers that can cross the blood-
brain barrier (regardless of their size and hydrophilicity), selectively bind, remove and 
“redox-silence” transition metals provide promising potential for therapeutic intervention 
(132). Engineered nanomaterials may be also act as targeted enhancers of oxidative stress 
for tumor or cancer therapy. Chemical modification of fullerenes can target mitochondria 
inducing significant mitochondrial ROS formation leading to enhanced apoptosis and 
necrosis (26). Alternatively, “minor” mitochrondrial ROS formation is thought to 
“precondition” by preventing propagation of mitochrondrial ROS during oxidative insults, 
thus providing potential opportunities for the development of nano antioxidants (26). Thus, 
ROS targeted strategies for either enhancement or prevention of oxidative stress may offer 
useful approaches for therapeutic interventions in the treatment of cancer, mitochrondial 
disease, and aging disease such as in the case of Alzheimer’s disease.
CONCLUSION
In summary, emerging research on engineered nanoparticles (i.e., CNTs), as well as on 
nanoparticles in ambient air particle pollution have demonstrated that oxidative stress can be 
an important mechanism for toxicity and potential health effects in the lung. There are 
number of pathways and intrinsic/extrinsic nanoparticle properties by which an imbalance in 
the prooxidant and antioxidant equilibrium can result in an oxidative stress state. The 
presence of transition metal catalysts, organic compounds which can undergo redox cycling, 
as well as other surface chemistries (functionalization) can influence the intrinsic potential 
of nanoparticles to produce oxidative species. Additionally, the biodegradability and 
biopersistence of nanoparticles are likely to influence the nanoparticle-cellular interactions 
which in turn may have direct effects on the cellular or organelle oxidative status (e.g., 
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mitochondrial cell signaling) or indirect effects through inflammatory processes (e.g., 
oxidative burst and phagolysosome activation) and enzymatic detoxification pathways. 
Certainly, genetic or epigenetic phenotypes that influence the prooxidant or antioxidant 
capacity (e.g., polymorphisms in GST) of an individual may have implications for the 
susceptibility of oxidative stress and potential health effects following exposure to 
engineered or incidental nanoparticles. Past experience with particles or fibers like asbestos 
and silica would suggest that characteristics such as surface reactivity, morphology, and 
biopersistence that influence the generation of reactive oxygen species, persistent 
inflammation, impaired macrophage clearance, and fibrotic lesions would likely be 
important parameters for driving the hazards of carbon nanotubes. Additional research in the 
area of engineered nanomaterials will likely continue to focus on the role of transition 
metals in the generation of ROS, length and morphology in influencing particle fate and 
transport, and surface chemistry (functional groups, dangling bonds) in directing cellular 
responses.
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Nanoparticles exhibit intrinsic oxidant-generating properties. Nanoparticles may contain 
transition metals due to particle engineering or as a by-product capable of generating ROS 
through Fenton-like chemical reactions. Free radical intermediates present on reactive 
nanoparticle surfaces and redox active groups (e.g., quinones) on nanoparticles are capable 
of redox cycling producing superoxide or hydroxyl radicals. Nanoparticles with 
semiconductor properties are capable of generating superoxide via electron jumping from 
the conduction band to oxygen and photocatalytic capable nanoparticles facilitate the 
creation of electron-hole pairs generating ROS such as superoxide or hydroxyl radicals. 
Also, nanoparticles generate and contribute to oxidative stress through direct and indirect 
cellular interactions. Nanoparticle interaction and damage to internal cellular structures such 
as lysosomes, mitochondria and the nucleus, can lead to cellular damage and oxidative 
stress. Through direct gene interaction with nanoparticles or nuclear oxidative stress, 
activation of signaling pathways for antioxidant or pro-oxidant responses may be up-
regulated. Additionally, nanoparticles may indirectly interact with cells to alter ROS 
production and emission through modified cellular phagocytic activity and oxidative burst.
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Oxidative stress reflects the imbalance between the generation of ROS and the biochemical 
mechanisms to detoxify and repair resulting damage of reactive intermediates. Antioxidant 
defense, inflammation, and toxicity follow a continuum from adaption and compensation of 
oxidant stresses to an in equilibrium whereby the protective antioxidant mechanisms 
breakdown or are overwhelmed.
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Bright field (A) and polarized field (B) images of a first generation respiratory bronchiole 
from a human lung of a 32 year old farm laborer. The inset in panel A and shown in panel B 
contains numerous polarized particles within intraluminal macrophages as well as within the 
walls of the respiratory bronchiole and adjacent alveoli. (Reproduced by permission, 
Environmental Health Perspectives)
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Light micrographs of contiguous first-, second- and third-generation respiratory bronchioles 
from the human lung showing the normal structural anatomy (A) and marked alterations (B) 
due to increased amounts of interstitial collagen, smooth muscle and visible pigment. These 
structural changes are most dramatic in the first generation respiratory bronchiole with a 
progressive decrease in more distal generations. (Reproduced by permission, Environmental 
Health Perspectives)
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